Decrease of CD154 intensity on peripheral CD4 + T cells in autoimmune thyroid disease
Author(s) -
WATANABE M.,
YAMAMOTO N.,
MATSUZUKA F.,
MIYAUCHI A.,
IWATANI Y.
Publication year - 2004
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/j.1365-2249.2004.02482.x
Subject(s) - cd154 , pathogenesis , immunology , graves' disease , autoimmune disease , peripheral , euthyroid , t cell , medicine , cd8 , thyroid , cd40 , immune system , biology , cytotoxic t cell , antibody , in vitro , biochemistry
SUMMARY To clarify immunological differences among patients with Graves’ disease (GD) and Hashimoto's disease (HD) at various levels of severity, we examined the expression of the CD154 molecules on peripheral T cells, which regulate B cell activation, B cell differentiation, and T‐cell survival. We found decreases in the intensities of CD154 on peripheral CD4 + cells from euthyroid patients with GD and HD, but we did not find any differences between patients with different disease severities. CD8 + cells did not express CD154 molecules. Thus, CD154 expression on CD4 + cells may be related to the pathogenesis of the autoimmune thyroid diseases, not to the disease severity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom